{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:35:18Z","timestamp":1792204518191,"version":"4.4.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.atherosclerosis.2018.07.004","type":"journal-article","created":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T17:26:47Z","timestamp":1530725207000},"page":"39-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Plasma high density lipoproteins: Therapeutic targeting and links to atherogenic inflammation"],"prefix":"10.1016","volume":"276","author":[{"given":"Alan R.","family":"Tall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib1","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease","volume":"302","author":"Emerging Risk Factors","year":"2009","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/353265a0","article-title":"Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI","volume":"353","author":"Rubin","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib3","doi-asserted-by":"crossref","first-page":"9607","DOI":"10.1073\/pnas.91.20.9607","article-title":"Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse","volume":"91","author":"Plump","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib4","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1172\/JCI114558","article-title":"Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit","volume":"85","author":"Badimon","year":"1990","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1161\/CIRCRESAHA.114.300760","article-title":"High-density lipoprotein and atherosclerosis regression: evidence from preclinical and clinical studies","volume":"114","author":"Feig","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1161\/CIRCRESAHA.116.308357","article-title":"Patients with coronary endothelial dysfunction have impaired cholesterol efflux capacity and reduced HDL particle concentration","volume":"119","author":"Monette","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib7","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1161\/CIRCULATIONAHA.116.025678","article-title":"Cholesterol efflux capacity, high-density lipoprotein particle number, and incident cardiovascular events: an analysis from the JUPITER trial (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin)","volume":"135","author":"Khera","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib8","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S2213-8587(15)00126-6","article-title":"Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study","volume":"3","author":"Saleheen","year":"2015","journal-title":"The lancet Diabetes & endocrinology"},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"Khera","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib10","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","article-title":"HDL cholesterol efflux capacity and incident cardiovascular events","volume":"371","author":"Rohatgi","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib11","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1161\/ATVBAHA.113.301373","article-title":"Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks","volume":"33","author":"Li","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib12","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(12)60312-2","article-title":"Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study","volume":"380","author":"Voight","year":"2012","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib13","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-024911-4.50008-8","article-title":"The metabolic role of lecithin: cholesterol acyltransferase: perspectives from pathology","volume":"11","author":"Glomset","year":"1973","journal-title":"Adv. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib15","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1161\/01.RES.0000170946.56981.5c","article-title":"New insights into the regulation of HDL metabolism and reverse cholesterol transport","volume":"96","author":"Lewis","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib16","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1161\/CIRCULATIONAHA.111.066589","article-title":"Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport","volume":"125","author":"Rosenson","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib17","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/11905","article-title":"Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency","volume":"22","author":"Brooks-Wilson","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib18","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1126\/science.271.5248.518","article-title":"Identification of scavenger receptor SR-BI as a high density lipoprotein receptor","volume":"271","author":"Acton","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib19","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1056\/NEJM199011013231803","article-title":"Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation","volume":"323","author":"Inazu","year":"1990","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib20","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib21","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1161\/01.ATV.0000054658.91146.64","article-title":"Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis","volume":"23","author":"Barter","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib22","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/j.jacc.2012.07.045","article-title":"Genetic inhibition of CETP, ischemic vascular disease and mortality, and possible adverse effects","volume":"60","author":"Johannsen","year":"2012","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1161\/CIRCRESAHA.117.311145","article-title":"Protein-truncating variants at the cholesteryl ester transfer protein gene and risk for coronary heart disease","volume":"121","author":"Nomura","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib24","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jacc.2016.11.056","article-title":"Systematic evaluation of pleiotropy identifies 6 further loci associated with coronary artery disease","volume":"69","author":"Webb","year":"2017","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib25","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"Effects of dalcetrapib in patients with a recent acute coronary syndrome","volume":"367","author":"Schwartz","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib26","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJMoa1609581","article-title":"Evacetrapib and cardiovascular outcomes in high- risk vascular disease","volume":"376","author":"Lincoff","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib27","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJMoa1706444","article-title":"Effects of anacetrapib in patients with atherosclerotic vascular disease","volume":"377","author":"Group","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib28","doi-asserted-by":"crossref","first-page":"9774","DOI":"10.1073\/pnas.0403506101","article-title":"ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins","volume":"101","author":"Wang","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cmet.2005.01.002","article-title":"ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation","volume":"1","author":"Kennedy","year":"2005","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib30","doi-asserted-by":"crossref","first-page":"28240","DOI":"10.1074\/jbc.M003337200","article-title":"Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor\/retinoid X receptor","volume":"275","author":"Costet","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib31","doi-asserted-by":"crossref","first-page":"39438","DOI":"10.1074\/jbc.M105863200","article-title":"Characterization of the human ABCG1 gene: liver X receptor activates an internal promoter that produces a novel transcript encoding an alternative form of the protein","volume":"276","author":"Kennedy","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib32","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nri3793","article-title":"Cholesterol, inflammation and innate immunity","volume":"15","author":"Tall","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib33","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/CIRCULATIONAHA.108.793869","article-title":"Increased inflammatory gene expression in ABC transporter-deficient macrophages: free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions","volume":"118","author":"Yvan-Charvet","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib34","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1161\/CIRCRESAHA.110.217281","article-title":"ABCA1 and ABCG1 protect against oxidative stress- induced macrophage apoptosis during efferocytosis","volume":"106","author":"Yvan-Charvet","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib35","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1172\/JCI57559","article-title":"ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice","volume":"121","author":"Murphy","year":"2011","journal-title":"The Journal of clinical investigation"},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib36","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.stem.2012.04.024","article-title":"Regulation of hematopoietic stem and progenitor cell mobilization by cholesterol efflux pathways","volume":"11","author":"Westerterp","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib37","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1126\/science.1189731","article-title":"ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation","volume":"328","author":"Yvan-Charvet","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib38","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1161\/ATVBAHA.113.303097","article-title":"Interleukin-3\/Granulocyte macrophage colony- stimulating factor receptor promotes stem cell expansion, monocytosis, and atheroma macrophage burden in mice with hematopoietic ApoE deficiency","volume":"34","author":"Wang","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib39","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1161\/CIRCRESAHA.114.300738","article-title":"ATP-binding cassette transporters, atherosclerosis, and inflammation","volume":"114","author":"Westerterp","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib40","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.113.301086","article-title":"Deficiency of ATP-binding cassette transporters A1 and G1 in macrophages increases inflammation and accelerates atherosclerosis in mice","volume":"112","author":"Westerterp","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib41","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1161\/ATVBAHA.115.306670","article-title":"Deficiency of ATP-binding cassette transporters A1 and G1 in endothelial cells accelerates atherosclerosis in mice","volume":"36","author":"Westerterp","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib42","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.117.032636","article-title":"Cholesterol efflux pathways suppress inflammasome activation, netosis and atherogenesis","author":"Westerterp","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib43","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib44","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1161\/CIRCRESAHA.114.303312","article-title":"Peptidylarginine deiminase inhibition reduces vascular damage and modulates innate immune responses in murine models of atherosclerosis","volume":"114","author":"Knight","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib45","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1161\/CIRCRESAHA.117.312494","article-title":"Roles of PAD4 and NETosis in experimental atherosclerosis and arterial injury: implications for superficial erosion","volume":"123","author":"Franck","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib46","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/CIRCRESAHA.116.309692","article-title":"Neutrophil extracellular traps in atherosclerosis and atherothrombosis","volume":"120","author":"Doring","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib47","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cmet.2013.03.009","article-title":"Impaired cholesterol efflux in senescent macrophages promotes age-related macular degeneration","volume":"17","author":"Sene","year":"2013","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib48","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.yjmcc.2017.05.001","article-title":"Plasma metabolite profiles, cellular cholesterol efflux, and non-traditional cardiovascular risk in patients with CKD","volume":"112","author":"Ganda","year":"2017","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib49","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1161\/CIRCULATIONAHA.107.741314","article-title":"Reduced expression of ATP-binding cassette transporter G1 increases cholesterol accumulation in macrophages of patients with type 2 diabetes mellitus","volume":"117","author":"Mauldin","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib50","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1194\/jlr.M003525","article-title":"Diabetes reduces the cholesterol exporter ABCA1 in mouse macrophages and kidneys","volume":"51","author":"Tang","year":"2010","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib51","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.2337\/db15-0575","article-title":"RAGE suppresses ABCG1-mediated macrophage cholesterol efflux in diabetes","volume":"64","author":"Daffu","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022142","article-title":"Type 2 diabetes is associated with reduced ATP-binding cassette transporter A1 gene expression, protein and function","volume":"6","author":"Patel","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib53","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1210\/jc.2017-01551","article-title":"Glycation reduces the stability of ApoAI and increases HDL dysfunction in diet-controlled type 2 diabetes","volume":"103","author":"Kashyap","year":"2018","journal-title":"J.\u00a0Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib54","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2011.18","article-title":"Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome","volume":"2","author":"Menu","year":"2011","journal-title":"Cell Death & Disease"},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib56","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bbrc.2012.07.058","article-title":"Critical role of caspase-1 in vascular inflammation and development of atherosclerosis in Western diet-fed apolipoprotein E-deficient mice","volume":"425","author":"Usui","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib57","doi-asserted-by":"crossref","first-page":"507208","DOI":"10.1155\/2014\/507208","article-title":"Silence of NLRP3 suppresses atherosclerosis and stabilizes plaques in apolipoprotein E-deficient mice","volume":"2014","author":"Zheng","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib58","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.116.308362","article-title":"Ogg1-Dependent DNA repair regulates NLRP3 inflammasome and prevents atherosclerosis","volume":"119","author":"Tumurkhuu","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib59","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib60","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2018.07.004_bib61","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1126\/science.aag1381","article-title":"Clonal hematopoiesis associated with Tet2 deficiency accelerates atherosclerosis development in mice","volume":"355","author":"Fuster","year":"2017","journal-title":"Science"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915018312000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915018312000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T23:50:30Z","timestamp":1661557830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915018312000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":61,"alternative-id":["S0021915018312000"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.07.004","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma high density lipoproteins: Therapeutic targeting and links to atherogenic inflammation","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}